Amedisys Inc financial data

Symbol
AMED on Nasdaq
Location
3854 American Way, Suite A, Baton Rouge, Louisiana
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 107 % +2.56%
Debt-to-equity 87 % +2.78%
Return On Equity 8.11 % +3704%
Return On Assets 4.44 % +3656%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.7M shares +0.41%
Common Stock, Shares, Outstanding 32.7M shares +0.4%
Entity Public Float 2.6B USD -13.3%
Weighted Average Number of Shares Outstanding, Basic 32.7M shares +0.39%
Weighted Average Number of Shares Outstanding, Diluted 33M shares +1.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 591M USD +6.91%
General and Administrative Expense 831M USD +5.26%
Costs and Expenses 2.13B USD +3.17%
Operating Income (Loss) 160M USD -3.2%
Nonoperating Income (Expense) -16.5M USD +85.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 144M USD +195%
Income Tax Expense (Benefit) 51.8M USD +9.61%
Net Income (Loss) Attributable to Parent 92M USD +3848%
Earnings Per Share, Basic 2.81 USD/shares +3022%
Earnings Per Share, Diluted 2.81 USD/shares +4583%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 150M USD +57.1%
Accounts Receivable, after Allowance for Credit Loss, Current 357M USD +28%
Other Assets, Current 26.1M USD +14.5%
Assets, Current 556M USD +30.3%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 44.7M USD +22.7%
Operating Lease, Right-of-Use Asset 84.7M USD -0.53%
Intangible Assets, Net (Excluding Goodwill) 101M USD -3.74%
Goodwill 1.24B USD 0%
Other Assets, Noncurrent 86.6M USD +2.02%
Assets 2.12B USD +6.81%
Accounts Payable, Current 26.6M USD -30.9%
Employee-related Liabilities, Current 136M USD +10.5%
Accrued Liabilities, Current 147M USD +7.05%
Liabilities, Current 480M USD +3.8%
Long-term Debt and Lease Obligation 351M USD -4.99%
Deferred Income Tax Liabilities, Net 47.2M USD +68.1%
Operating Lease, Liability, Noncurrent 59M USD -1.05%
Other Liabilities, Noncurrent 845K USD -48.1%
Liabilities 938M USD +1.83%
Retained Earnings (Accumulated Deficit) 795M USD +13.1%
Stockholders' Equity Attributable to Parent 1.13B USD +11.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.18B USD +11.1%
Liabilities and Equity 2.12B USD +6.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.54M USD -125%
Net Cash Provided by (Used in) Financing Activities -8.55M USD +85%
Net Cash Provided by (Used in) Investing Activities -3.07M USD -107%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 38.2M shares +0.58%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 157M USD +41.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.19M USD +23.1%
Deferred Tax Assets, Valuation Allowance 5.4M USD +3.85%
Deferred Tax Assets, Gross 76.4M USD -1.55%
Operating Lease, Liability 89M USD -13.6%
Payments to Acquire Property, Plant, and Equipment 2.67M USD +97.8%
Lessee, Operating Lease, Liability, to be Paid 96.8M USD -11.7%
Property, Plant and Equipment, Gross 134M USD +14.4%
Operating Lease, Liability, Current 26.4M USD +2.56%
Lessee, Operating Lease, Liability, to be Paid, Year Two 26.1M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 29.5M USD -18.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +29.4%
Deferred Income Tax Expense (Benefit) 2.59M USD -6.42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.8M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.7M USD -5.29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.2M USD +3.94%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.14M USD +7.8%
Deferred Tax Assets, Net of Valuation Allowance 71M USD -1.93%
Interest Expense 32.3M USD +25.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%